Matrix Asset Management

Matrix Asset Management is a wealth management company based in Vancouver, British Columbia, offering services to both individual and institutional investors throughout Canada. Established in 1998, the company operates through three divisions: GrowthWorks Capital Ltd, a venture capital firm; Matrix Funds Management Inc; and SEAMARK Asset Management Ltd. Each division specializes in different aspects of asset management, providing a comprehensive range of investment solutions tailored to meet the diverse needs of its clients.

Clint Matthews

CFO

4 past transactions

EmerGeo Solutions

Venture Round in 2010
EmerGeo Solutions Worldwide Inc. specializes in the development and support of emergency management software and services aimed at enhancing crisis response and safety for governments and industries globally. The company offers integrated products such as Fusionpoint, a web-based crisis information management system, and a mapping software suite designed to facilitate multi-agency interoperability and real-time situational awareness. These tools enable clients to effectively prepare for, respond to, and recover from various incidents, including natural disasters and acts of terrorism. EmerGeo Solutions, headquartered in Vancouver, Canada, has successfully deployed its software to a diverse range of clients across North America, Australia, and the Middle East. Founded in 1997, the company was previously known as Kavalmedia Services Ltd. before rebranding in 2008.

Morega Systems

Series B in 2010
Morega Systems Inc. is a software and consumer product company that specializes in advanced media mobility solutions tailored for the digital home. The company develops software and services that facilitate multimedia portability and streaming for business customers globally. With capabilities in transcoding, transcrypting, and quality of service-aware streaming, Morega offers comprehensive solutions for premium service operators and hardware vendors. Their applications include side-loading, place-shifting, and targeted ad insertion, enhancing consumer experiences with innovative products that enable seamless access to both premium and personal media content. Additionally, Morega utilizes a remote proxy server to manage network addresses, ensuring consumers can easily access pictures, music, and video on any IP device.

Blueprint Software Systems

Venture Round in 2010
Blueprint Software Systems Inc. is a software development company that specializes in creating solutions to assist organizations in building business and software applications. Founded in 2003 and headquartered in Toronto, Canada, the company offers a range of products designed to streamline digital transformation processes for large enterprises. Its flagship offerings include Blueprint Storyteller, which facilitates collaboration among stakeholders by auto-generating user stories and acceptance criteria, and Blueprint Regulatory Compliance Manager, which addresses complex compliance needs. The company's platform supports key functions such as process modeling, task capture, and robotic process automation, while promoting alignment between business and IT strategies. Blueprint's solutions emphasize regulatory compliance, enhance project visibility through detailed reporting and analytics, and integrate with existing agile development tools. Serving a diverse clientele that includes Fortune 100 companies across various sectors, Blueprint Software Systems is recognized for its ability to address the intricate challenges of digital transformation.

Valocor Therapeutics

Venture Round in 2010
Valocor Therapeutics, Inc. is a clinical-stage biotechnology company based in Vancouver, Canada, focused on developing innovative therapies for dermatological conditions that lack effective treatments. The company's product pipeline includes Lemuteporfin, a targeted topical photodynamic therapy for severe acne, and VAL-001, a topical sebum inhibitor aimed at reducing acne and sebaceous gland hyperactivity. Additionally, Valocor is developing VAL-002, a small-molecule kinase inhibitor designed for the topical treatment of chronic inflammatory skin diseases, and VAL-003, a kinase inhibitor with dual functions in melanin stimulation and immune modulation. Founded in 2008, Valocor Therapeutics is dedicated to addressing significant unmet medical needs in dermatology through its advanced therapeutic solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.